Clinical Trial Update: The Effect of Ketanserin on the Microcirculation in Sepsis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ketanserin's effect on microcirculation in patients with sepsis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Ketanserin (ketanserin)

Snippet

Sponsor: Frisius Medisch Centrum | Conditions: Severe Sepsis, Septic Shock | Phase 3 | Status: COMPLETED